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Abstract
Background: Randomised studies consistently show that Community Treatment Orders (CTOs) do not have the
intended effect of preventing relapse and readmissions of patients with severe and enduring mental illness. Critics
suggest this in part can be explained by RCTs studying newly introduced CTO regimes and that patients therefore
were not brought back to hospital for short-term observations (‘recall’) as frequently as intended. Our purpose was (i)
to test the hypothesis that CTO practice as regards recall of patients to hospital in England and Wales was as rigorous
under the OCTET trial period as in current routine use and (ii) to investigate the reasons for and outcomes of recalls
and whether this changed over time.
Method: Thirty six-month observational prospective study of 198 patients in the OCTET Follow-up Study.
Results: Forty percent of patients were recalled, 19 % more than once. This is in line with current national use.
Deterioration in clinical condition was the most common reason for recalls (49 %), and 68 % of recalls resulted in
revocation of the order (i.e., retention in hospital under compulsion). This pattern remained stable over time.
Conclusion: The use of recall cannot explain why RCTs have not confirmed any benefits from CTOs, and their
continued use should be reconsidered.
Trial registration: The OCTET Trial was retrospectively registered on 12 November 2009 (ISRCTN73110773)
Keywords: Community Treatment Order, Community compulsion, Recall, Revocation, Outpatient Commitment,
OCTET trial
Background
Deinstitutionalisation of mental health services has re-
sulted in severely ill patients increasingly being treated
in the community. In response, legal regimes for invol-
untary out-patient treatment (Community Treatment
Orders, CTOs) have been developed. First introduced
in North America and Australasia, they are also becom-
ing a feature of mental health legislations in much of
Europe and are now available in more than 75 jurisdic-
tions worldwide [1]. CTOs permits compulsory treat-
ment outside of hospital. They target patients deemed
to need supervision but who are well enough for this to
take place outside hospital. The aim is to break the pat-
tern of repeated admissions by facilitating a period of
stability so that the patient settles in the community
and eventually returns to voluntary care.
CTOs were introduced into the amended Mental
Health Act for England and Wales (MHA) in November
2008 [2]. The legal criteria include that the patient
suffers from a mental disorder for which they require
treatment to protect their health and safety or that of
others; that the treatment (which must be available) can
continue in the community, and; that it is necessary for
the responsible clinician to be able to exercise the power
of rapid recall to hospital for observation [2]. Recalls
may take place when patients show signs of deterior-
ation or they breach one of the two mandatory condi-
tions of making themselves available for assessment. A
recall to hospital for observation or treatment can last
for up to 72 h after which there are three options. The
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order can be revoked and the patient remains in hospital
for involuntary treatment; they return to the community
on the CTO, or; they are discharged from involuntary
treatment altogether. The recall mechanism is thus cen-
tral to how CTOs were envisaged to work. Similar
mechanisms exist in other CTO regimes [3].
Current evidence shows that CTOs are not effective in
their stated purpose of reducing relapse and readmission
[4–6]. Around 35 outcome studies and three RCTs have
investigated the effect on hospitalisation (rates, duration
and time to readmission following placement on CTO)
and community service usage. While non-randomised
studies vary in quality and have inconsistent findings, all
analyses of randomised data found no effect of CTOs [4,
7–9]. A meta-analysis of the patients from the three RCTs
also found no effect on admissions or bed days or any im-
provement in psychiatric symptoms or global functioning
[7]. Additionally, the OCTET trial testing the English re-
gime [10] found no effect on subgroups [11] or any long-
term (36 months) effect on hospital outcomes or on en-
gagement with services [12].
One explanation advanced for the lack of observed posi-
tive effects of CTOs is that newly introduced regimes are
not implemented as rigorously as intended [4, 13, 14],
although there is little published data to support this
proposal. Specifically it is suggested that clinicians
were inexperienced in the use of CTOs when the
studies were conducted and that recall to hospital
was not used as often as intended, preventing patient
improvement [14, 15]. There is very little evidence on
which to base such claims of inadequate recalls because
this data is not reported in effectiveness studies. National
prevalence data in England and Wales show that on 31
March 2015, 5461 people were subject to a CTO. No data
is available on how long these patients had been on CTO.
In the preceding year, available incidence figures show that
2369 recalls and 1427 revocations were made. This would
suggest that around 43 % of CTO patients in that period
were recalled, but some may have been recalled more than
once so the true figure is probably lower. Of these recalls,
60 % ended in revocation. These figures have remained
stable over the last 5 years [16].
Aims of the study
To address the concern over the validity of the evidence
base, we tested the hypothesis that early implementation
of CTOs in England and Wales was equally rigorous in
terms of recalling patients as is the case routinely now
8 years after their introduction. We used data from the
three year follow-up of the OCTET cohort [12]. A sec-
ondary aim was to examine the reasons for and out-
comes of these recalls, and whether this changed over
time.
Methods
The OCTET trial recruited patients in 32 National Health
Service (NHS) hospitals across England and followed
them up for 12 months. At randomisation, all were in in-
voluntary hospital treatment, aged 18–65 years, with a
psychosis diagnosis and considered to need CTO on dis-
charge. Patients were randomly allocated (50:50) to leave
hospital on a CTO or to voluntary status via Section 17
leave of absence [10]. The OCTET Follow-Up Study then
followed the cohort of 333 patients for a further 24 months
(i.e., 36 months, 1095 days, in total) [12]. For the present
observational prospective cohort study we selected those
patients from the OCTET Follow-up Study who at any
time during the follow-up period were on a CTO. We ap-
plied no further inclusion or exclusion criteria.
For each patient we used data from the date of first
placement on CTO until 36-months after randomisation
in the original trial. Data were collected, by independent
researchers, from NHS medical records, including trusts’
Mental Health Act Offices, in the period from November
2008 to February 2014. Socio-demographic and clinical
characteristics were collected through patient interviews
at baseline [10, 12].
The number of occurrences of recalls was counted. For
each recall we classified the recorded reasons in pre-
defined categories (deterioration in health; medication non-
compliance; disengagement), and recorded their outcomes
(continued CTO; revocation; discharge to voluntary care).
To allow investigation of whether practice changed over
time, either with experience of individual patients or with
increased familiarity with the CTO regime, we used two
separate methods. First, we examined the reason for and
outcome of patients’ first, second, third and fourth recall.
Second, we divided the data on patients’ first ever recalls
in two time periods: period 1, the 0–12 months of a pa-
tient’s participation in the study (0–365 days) and period
2, 13–36 months in the study (366–1095 days).
Global functioning and severity of symptoms were
assessed at baseline, using the Global Assessment of
Functioning (GAF) [17] and the Brief Psychiatric Rating
Scale (BPRS) [18] respectively.
We report the number and percentage of observed
values for binary and categorical variables and, depend-
ing on data distribution, mean with standard deviation
(SD) or median with interquartile range (IQR) for con-
tinuous variables. The descriptive statistics are provided
for the whole sample and by time period.
Results
Sample and baseline characteristics
Of the 333 patients in the OCTET Follow-up study,
198 were subject to a CTO during the 36 months
and so included in this analysis. Socio-demographic
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and clinical characteristics of the sample at baseline
are displayed in Table 1.
Patients were predominantly male (68 %, 135/198) and
the mean age was 39.6 (SD 11.2). They had a mean of 11.9
(SD 1.7) years of education (12 years of education is
mandatory in the UK). Over half were White (58 %, 114/
198), a quarter were Black (26 %, 51/198) and the remain-
der were Asian (10 %, 19/198) or of mixed or ‘other’ eth-
nic origin (7 %, 14/198). The majority of patients suffered
from schizophrenia (84 %, 166/198) and the median dur-
ation of illness was 12 years (IQR 6, 20). The median level
of symptoms, measured by the BPRS was 39 (IQR 33,45)
and the median level of functioning as measured by the
GAF was 38.5 (IQR 31,48.5), indicating a severely ill group
of people. They had a median of 6 (IQR 3, 9) previous
hospital admissions. Almost half the sample (42 %, 83/
198) had criminal convictions and a third (28 %, 55/198)
had been imprisoned.
Rate of recall to hospital
As shown in Table 2, a total of 136 recalls were made,
around one for every two CTOs. 40 % of the patients (78/
198) were recalled, and 19 % (37/198) were recalled twice.
8 % (15/198) were recalled three times and 3 % patients
(6/198) had four to six recalls.
Reasons for and outcomes of recalls
The reasons for and outcomes of all recalls are presented
in Table 2, which also presents this information on succes-
sive recalls and on first recalls in periods 1 and 2.






Age (years) 0 0 % 39.6 (11.2)
Male 0 0 % 135 68 %
Years of education 3 2 % 11.9 (1.7)
Ethnicity 0 0 % - -
White - - 114 58 %
Black - - 51 26 %
Asian - - 19 10 %
Mixed and other - - 14 7 %
Born in UK 0 0 % 155 78 %
Social/living situation
Married/co-habiting 1 1 % 16 8 %
Patients with identified carer 20 10 % 72 36 %
Independent accommodation 2 1 % 147 74 %
Living alone/homeless 12 6 % 143 72 %
Clinical status
Schizophrenia 0 0 % 166 84 %
Brief Psychiatric Rating Scale (BPRS) 14 7 % 39 [33, 45]
Global Assessment of Functioning (GAF) 15 8 % 38.5 [31, 48.5]
Clinical history
Duration of illness (years) 4 2 % 12 [6,20]
Patients with duration of illness less than 2 years 0 0 % 7 4 %
Number of past hospital admissions 11 6 % 6 [3, 9]
Months of past hospital stay 29 15 % 16 [8, 28]
Number of past involuntary hospital admissions 19 10 % 4 [2, 7]
Criminal history
Convictions 15 8 % 83 42 %
Imprisonment 13 7 % 55 28 %
CTO = community treatment orders
- = not applicable
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Deterioration of health was the recorded reason for
half of all recalls (49 %, 67/136). Non-compliance with
medication was the reason for 19 % of recalls (26/136)
and disengagement in 8 % of cases (11/136). There was
no reason recorded for 33 % (26/78) of first recalls.
Deterioration of health applied to 59 % (22/37) of pa-
tients experiencing a second recall. For those patients who
had their first recall in period 2, this was even higher, with
76 % (25/33) compared with 24 % (11/45) of those recalled
in period 1. Non-compliance as a reason remained stable
for first recalls over time periods, but there was an in-
crease in non-compliance as the recorded reason for
recalling patients for the second or third time. Non-
recording decreased with subsequent recalls and also be-
tween period 1 and 2 from 53 % (24/45) to 6 % (2/33).
Sixty eight percent of all recalls (92/136) ended in revo-
cation and the patient returning to involuntary hospital
treatment. Patients remained on CTO after 31 % of all
recalls (42/136). Only 1 % of recalls (2/136) ended in dis-
charge from involuntary treatment. Fewer recalls ended in
revocation in period 1 (64 %, 29/45) than in period 2
(73 %, 24/33).
Discussion
Our sample consisted of severely ill psychosis patients
with long histories of hospital admissions. The charac-
teristics of the sample are similar to those reported in
national and international studies [4, 5, 19–22].
We found that 40 % of CTO patients were recalled to
hospital at least once and 19 % more than once. As we
have previously reported, the 198 patients stayed on CTO
for one year on average (median 346 days, IQR 180–724)
[12], which means our recall rate of 40 % is broadly com-
parable with the current national rate of around 43 % over
12 months [16]. This supports our hypothesis that the use
of recall to hospital during the OCTET trial was as rigor-
ous as in the current, mature system.
These findings are in line with local studies: A 12 month
follow-up of 65 CTOs in North England reported a 40 %
recall rate over 12 months [21] and an audit of 50 CTOs
in North Wales reported a 34 % recall rate [23]. These
studies reported very different rates of revocation, how-
ever, 96 % [21] and 34 % [23] respectively. Two 6-month
follow-ups (of 104 and 67 patients respectively) saw lower
recall rates of 19 % [19] and 13 % [24], possibly due to the
short time frame. They also reported high revocation rates
of 70 % [19] and 100 % [24]. Nationally, 60 % of recalls
ended in revocation during 2014/15 [16]; our rate of 68 %
was slightly higher. There is a paucity of international
studies of recall and revocation, but one small study from
Victoria, Australia report a 62 % revocation level [25].
Half of all recalls in our study (49 %) were due to deteri-
oration in the patients’ mental state and a fifth due to medi-
cation non-compliance. There was a large increase from
period 1 to period 2 in clinical deterioration being recorded
as the reason for first recalls. This could signify a change in
use. However as the number of recalls with no recorded
reason decreased from 53 % to 6 % it is more likely that this
reflects improved record keeping. The majority of recalls
(68 %) ended in revocation, and there was a slight increase
over time. A third of recalls resulted in the patient return-
ing to the community on the CTO. Only two recalls (1 %)
resulted in discharge from compulsion. Overall, these
findings suggest recalls were used as intended to intervene
during relapse.
There has been some concern over clinicians’ under-
standing of when to use recall [26, 27], but even so, both
our study and national figures suggest their use has
remained stable over time. Our findings indicate that deci-
sions to recall patients are based on judgements of the
Table 2 Reasons for and outcomes of recalls of 78 patients over 36 months by CTO and by time period
All recalls 1st recall 2nd recall 3rd recall 4th – 6th recall 1st recall
0th–12th month 13th–36th month
(N = 136) (N = 78) (N = 37) (N = 15) (N = 6) (N = 45) (N = 33)
n % n % n % n % n % n % n %
Reasons for recall
Not recorded 29 21 % 26 33 % 1 3 % 2 13 % 0 0 % 24 53 % 2 6 %
Deterioration of health 67 49 % 36 46 % 22 59 % 7 47 % 2 33 % 11 24 % 25 76 %
Medication non-compliance 26 19 % 10 13 % 8 22 % 6 40 % 2 33 % 6 13 % 4 12 %
Disengagement 11 8 % 4 5 % 5 14 % 0 0 % 2 33 % 2 4 % 2 6 %
Other 3 2 % 2 3 % 1 3 % 0 0 % 0 0 % 2 4 % 0 0 %
Recall outcomes
Revoked (to sec. 3, inpatient) 92 68 % 53 68 % 27 73 % 10 67 % 2 33 % 29 64 % 24 73 %
Continued CTO 42 31 % 24 30 % 9 24 % 5 33 % 4 67 % 15 33 % 9 27 %
Discharged to voluntary care 2 1 % 1 1 % 1 3 % 0 0 % 0 0 % 1 2 % 0 0 %
CTO Community Treatment Order
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patient’s clinical state. This is also how psychiatrists explain
their use of CTOs [28, 29], and it is in line with current
legal understanding of how recall may be used [26].
Strength and weaknesses
This descriptive analysis is the first to investigate CTO
recalls over a prolonged period of 36 months. A key
strength is the degree of data completeness for a group
of severely ill patients [12]. They were recruited from 32
different NHS hospitals, covering both urban and rural
areas [10]. Information on the reasons for recall was not
comprehensively recorded in patient records early in the
process. Percentages calculated from small sub-samples
should be interpreted with caution. Our sample consists
of patients recruited to the OCTET trial, which means it
is restricted to those deemed suitable for CTO by clini-
cians who were in equipoise about the benefit of CTO
vs. the control condition.
Conclusions
Our findings support our hypothesis that the use of recall
of CTO patients to hospital over the course of the OCTET
RCT was in line with mature practice nationally. We have
also shown that the use of recall, its reasons and outcomes
did not change over time, contrary to what has been sug-
gested as explanations for the absence of positive effects of
CTOs in RCTs. There is a lack of published research on
the rates, reasons and outcomes of short-term recalls of
patients to hospital as part of the CTO process, and this
should be a focus for future research, particularly to facili-
tate international comparisons.
Our findings lend support to the conclusions of exist-
ing RCTs by demonstrating that the CTOs in the
OCTET trial were implemented in line with routine
practice. This strengthens the evidence that CTOs do
not achieve their stated aims of improving hospital out-
comes and that their use should be urgently
reconsidered.
Abbreviations
BPRS: Brief Psychiatric Rating Scale; CTO: Community Treatment Order;
GAF: Global Assessment of Functioning; IQR: Interquartile range;
MHA: Mental Health Act; NHS: National Health Service; OCTET: Oxford
Community Treatment Order Evaluation Trial; RCT: Randomised controlled
trial; SD: Standard deviation
Acknowledgements
This article presents independent research funded by the National Institute
of Health Research (Program Grant for Applied Research, grant number RP-
PG-0606-1006). The views expressed in this publication are those of the
authors and not necessarily those of the NHS, the NIHR or the Department
of Health. We are grateful to the OCTET researchers: Caroline Bennett, Kiki
Burns, Krysia Canvin, Alexandra Forrest, Lindsey Johnston, Naomi Lewis, Sarah
Masson, Andrew Molodynski, Lucy Murray, Helen Nightingale, Riti Patel,
Stephen Puntis, Lisa Russell, Aonghus Ryan, Tanya Smith, Anna Sulman,
Lucinda Turnpenny, Amy Mitchell, Maria Vazquez Montes, Francis Vergunst,
Claire Visser and Sue Woods-Ganz.
Funding
National Institute of Health Research, Program Grant for Applied Research,
grant number RP-PG-0606-1006.
Availability of data and material
The datasets collected and analysed in the current study is available from
the corresponding author on reasonable request.
Authors’ contributions
TB was PI on the study and it was managed by JR and KY. KY oversaw
data management. CK conducted all statistical analyses. All authors
contributed to the manuscript and agreed the final version.
Competing interest
JR is an Associate Editor of BMC Psychiatry.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Ethical approval was granted by the Staffordshire National Health Service
Research Ethics Committee (reference 08/H1204/131). All patients gave their
consent in writing prior to enrolment.
Author details
1Health Services Research Unit, Akershus University Hospital, 1478 Lørenskog,
Norway. 2Department of Psychiatry, University of Oxford, Oxford, UK.
3Department of Primary Care, University of Oxford, Oxford, UK.
Received: 17 August 2016 Accepted: 1 November 2016
References
1. Rugkåsa J, Molodynski A, Burns T. Introduction. In: Molodynski A, Rugkåsa J,
Burns T, editors. Coercion in Community Mental Health Care International
Perspectives. Oxford: Oxford University Press; 2016. p. 1–9.
2. Department of Health. Mental Health Act 2007: The Mental Health Act 2007
(Commencement No. 6 and After-care under Supervision: Savings,
Modifications and Transitional Provisions) Order 2008 Available from http://
www.legislation.gov.uk/uksi/2008/1210/article/6/made#article-6-j . Accessed
4 Nov 2016.
3. Swartz M, Swanson JW, Steadman HJ, Robbins PC, Monahan J. New York
State Assisted Outpatient Treatment Program Evaluation. Durham NC: Duke
University School of Medicine; 2009.
4. Churchill R, Owen G, Singh S, Hotopf M. International experiences of using
Community Treatment Orders. London: Institute of Psychiatry; 2007.
5. Rugkåsa J. Effectiveness of Community Treatment Orders: The International
Evidence. Canad J Pscyhiatr. 2016;61:15–24.
6. Dawson J. Community Treatment Orders: International Comparisons. Dunedin:
Otago University; 2005.
7. Kisely S, Hall K. An updated meta-analysis of randomized controlled evidence
for the effectiveness of community treatment order. Canad J Psychiatr. 2014;
59:561–4.
8. Kisely S, Campbell LA, Scott A, Preston NJ, Xiao J. Randomized and non-
randomized evidence for the effect of compulsory community and
involuntary out-patient treatment on health service use: systematic review
and meta-analysis. Psychol Med. 2007;37:3–14.
9. Maughan D, Molodynski A, Rugkåsa J, Burns T. A systematic review of the
effect of community treatment orders on service use. Soc Psychiatr Psychiatr
Epidemiol. 2014;49:651–63.
10. Burns T, Rugkåsa J, Molodynski A, et al. Community treatment orders for patients
with psychosis (OCTET): A randomised controlled trial. Lancet. 2013;381:1627–33.
11. Rugkåsa J, Vazquez Montes M, Visser C, et al. Community treatment orders:
Clinical and social outcomes, and a subgroup analysis from the OCTET RCT.
Acta Psychiatri Scand. 2015;131:321–9.
12. Burns T, Yeeles K, Koshiaris C, et al. Effect of increased compulsion on
readmission to hospital or disengagement from community services for
patients with psychosis: follow-up of a cohort from the OCTET trial. Lancet
Psychiatr. 2015;2:881–90.
13. Curtis D. OCTET does not demonstrate a lack of effectiveness for community
treatment orders. Psychiatr Bulletin. 2014;38:36–9.
Rugkåsa et al. BMC Psychiatry  (2016) 16:392 Page 5 of 6
14. Mustafa FA. On the OCTET and supervised community treatment orders.
Med Sci Law. 2014;54:116–7.
15. Swartz MS, Swanson JW. Involuntary outpatient commitment, community
treatment orders, and assisted outpatient treatment: what’s in the data?
Canad J Psychiatr. 2004;49:585–91.
16. HSCIC. Inpatients Formally Detained in Hospitals Under the Mental Health Act
1983 and Patients Subject to Supervised Community Treatment, England -
2014–2015, Annual figures: Health and Social Care Information Centre. 2016.
Available from www.hscic.gov.uk. Accessed 15 August 2016.
17. Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of
measures of social functioning. Am J Psychiatry. 1992;149:1148–56.
18. Lukoff D, Nuechterlein K, Ventura J. Manual for expanded brief psychiatric
rating scale (BPRS). Schizophr Bull. 1986;12:594–602.
19. Evans R, Makala J, Humphreys M, Mohan CRN. Supervised community treatment
in Birmingham and Solihull: first 6 months. The Psychiatrist. 2010;34:330–3.
20. Rawala M, Gupta S. Use of community treatment orders in an inner-London
assertive outreach service. Psychiatric Bulletin. 2014;38:13–8.
21. Smith M, Branton T, Cardno A. Is the bark worse than the bite? Additional
conditions used within community treatment orders. Psychiatric Bulletin.
2014;38:9–12.
22. Monnery D, Belgamwar RB. Use of Supervised Community Treatment in one
UK healthcare district. Prog Neurol Psychiatr. 2011;15:8–13.
23. Lepping P, Malik M. Community treatment orders: current practice and a
framework to aid clinicians. The Psychiatrist. 2013;37:54–7.
24. Malik M, Hussein N. Qualitative outcome for community treatment orders.
The Psychiatrist. 2009;33:437–8.
25. O’Donoghue B, Brophy L, Owens N, et al. Rate of community treatment orders
and readmission orders following reconfiguration of community mental health
services. Australasian Psychiatr. 2016;24:278–81.
26. Dawson J. Lawfulness of preventive recall from a community treatment order.
Br J Psychiatr. 2015;206:266–7.
27. Dudleston KE. Misunderstanding recall. Psychiatric Bulletin. 2014;38:139.
28. DeRidder R, Molodynski A, Manning C, McCusker P, Rugkåsa J. Community
treatment orders in the UK 5 years on: a repeat national survey of psychiatrists.
The Psychiatrist. 2015;40:119–23.
29. Canvin K, Rugkåsa J, Sinclair J, Burns T. Patient, psychiatrist and family carer
experiences of community treatment orders: Qualitative study. Soc Psychiatry
Psychiatr Epidemiol. 2014;49:1873–82.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Rugkåsa et al. BMC Psychiatry  (2016) 16:392 Page 6 of 6
